Further, inhibition of ferroptosis alleviates the progression of liver diseases, such as nonalcoholic fatty liver disease (NAFLD), drug-induced liver injury (DILI), virus hepatitis, liver fibrosis, and hepatocellular carcinoma (HCC)
This high-dose protocol is specifically designed for individuals facing severe tissue damage, complex injuries, or conditions requiring maximum regenerative support
Certification MOCRA / FDA Registered Manufactured in Spain Disclaimer To clarify, this product is intended for topical or external use only
GHK-Cu is found in the human body
There was also an improvement in the ratio of GSSG to GSH, with the largest decrease in this ratio among those taking the higher dose in the first and second weeks
2023 Jun 22